Women, patients younger than 30 years have higher rates of depression
FRIDAY, Sept. 18, 2020 (HealthDay News) — Depression is common among patients with psoriasis, according to a study published online Sept. 14 in Dermatology.
Albert Duvetorp, from Skåne University Hospital in Malmö, Sweden, and colleagues used data from the Swedish Prescribed Drug Register and electronic medical records (April 9, 2008, to Jan. 1, 2016) to assess the prevalence of pharmacologically treated depression among individuals with and without psoriasis in a Swedish population using International Classification of Diseases, Tenth Revision codes.
The researchers found that the risk for pharmacologically treated depression was higher in individuals with psoriasis (age- and sex-adjusted odds ratio, 1.55), with 21.1 percent of women with psoriasis receiving pharmacological treatment for depression compared with 14.2 percent of the control population. Compared with men with psoriasis, the prevalence of depression was significantly higher in women with psoriasis. Male and female patients with psoriasis younger than 31 years had the highest risk for suffering from depression.
“The results of the current study underline the need for dermatologists to adopt a holistic approach, looking beyond the skin, when handling patients with psoriasis in everyday clinical practice,” the authors write.
Mortality, Comorbidity Risk Increased With Generalized Pustular Psoriasis 
Youth Suicide Risk Linked to Community Firearm Violence 
150+ Minutes of Social Media Daily Tied to Depression in Adults 
Therapist-Led Online Cognitive Behavioral Therapy Aids Depression 
Air Pollution Tied to Higher Risk for Suicide 
Psychiatrists Only Agree 55 Percent of the Time on Diagnoses 
2021 to 2026 Saw Increase in State Funding for Suicide Prevention 
Screening + Online Cognitive Behavioral Therapy Program Aids Nurses" Mental Health 
